This announcement is a separate document:
川宁生物：北京中伦（成都）律师事务所关于伊犁川宁生物技术股份有限公司2023年限制性股票激励计划（草案）的法律意见书
Twinning Biotech: Legal opinion from Beijing Zhonglun (Chengdu) Law Firm on Yili Chuanning Biotechnology Co., Ltd.'s 2023 restricted stock incentive plan (draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated